Open AccessSocial disadvantage and variation in the incidence of end‐stage renal disease in Australian capital cities
Author(s) -
Cass Alan,
Cunningham Joan,
Wang Zhiqiang,
Hoy Wendy
Publication year - 2001
Publication title -
australian and new zealand journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.946
H-Index - 76
eISSN - 1753-6405
pISSN - 1326-0200
DOI - 10.1111/j.1467-842x.2001.tb00587.x
Subject(s) - incidence (geometry) , socioeconomic status , demography , residence , medicine , end stage renal disease , disadvantaged , disadvantage , census , dialysis , geography , disease , environmental health , population , economic growth , political science , law , physics , sociology , optics , economics
Objective: To evaluate variation in the incidence of end‐stage renal disease (ESRD) within Australian capital cities. To explore the relation between the incidence of ESRD and socio‐economic disadvantage.Methods: We obtained data from the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) regarding 5,013 patients from capital cities who started ESRD treatment between 1 April 1993 and 31 December 1998. We used the postcode at the start of treatment to calculate the average annual incidence of ESRD for each of 51 capital city regions using 1996 Census counts based on place of usual residence. We calculated standardised incidence ratios with 95% confidence intervals for each region. The standardised incidence ratios were examined in relation to the SEIFA Index of Relative Socio‐economic Disadvantage (IRSD), derived from the 1996 Census. Low IRSD values indicate more disadvantaged areas.Results: There is significant variation in the standardised incidence of ESRD within capital cities. There was a significant correlation ( r =‐0.41, p =0.003) between the standardised incidence ratio for ESRD and the SEIFA IRSD.Conclusions and implications: Capital city areas that are more disadvantaged have a higher incidence of ESRD. Socio‐economic factors may be important determinants of the risk of developing ESRD.